Astrocytes in neurodegenerative diseases (I): Function and molecular description;Astrocitos en las enfermedades neurodegenerativas (I): Función y caracterización molecular

Neurologia

Volumn 30, Issue 2, 2015, Pages 119-129

  Guillamon Vivancos T ^a   Gomez Pinedo U ^a   Matias Guiu J ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Astrocyte; Astrocytosis; Glia; Glial fibrillary acidic protein; Neurodegeneration; Neurodegenerative diseases

Indexed keywords

LIPOPROTEIN;

ASTROCYTE; ASTROCYTOSIS; BLOOD BRAIN BARRIER; BLOOD FLOW; CIRCADIAN RHYTHM; DEGENERATIVE DISEASE; ENERGY; LIPID METABOLISM; LIPOPROTEIN SECRETION; NERVOUS SYSTEM DEVELOPMENT; PLASTICITY; SHORT SURVEY; SYNAPTIC TRANSMISSION; GLIOSIS; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; ULTRASTRUCTURE;

ASTROCYTES; BLOOD-BRAIN BARRIER; GLIOSIS; HUMANS; NEURODEGENERATIVE DISEASES;

EID: 84926260708     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2012.12.007     Document Type: Short Survey

References (130)

1. Allen N.J., Barres B.A. Neuroscience: glia - more than just brain glue. Nature 2009, 457:675-677.
2. Rossi D., Volterra A. Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Res Bull 2009, 80:224-232.
3. Tower D.B., Young O.M. The activities of butyrylcholinesterase and carbonic anhydrase, the rate of anaerobic glycolysis, and the question of a constant density of glial cells in cerebral cortices of various mammalian species from mouse to whale. J Neurochem 1973, 20:269-278.
4. Ogata K., Kosaka T. Structural and quantitative analysis of astrocytes in the mouse hippocampus. Neuroscience 2002, 113:221-233.
5. Barres B.A. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 2008, 60:430-440.
6. Volterra A., Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 2005, 6:626-640.
7. Nedergaard M., Ransom B., Goldman S.A. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci 2003, 26:523-530.
8. Halassa M.M., Fellin T., Takano H., Dong J.H., Haydon P.G. Synaptic islands defined by the territory of a single astrocyte. J Neurosci 2007, 27:6473-6477.
9. Bushong E.A., Martone M.E., Jones Y.Z., Ellisman M.H. Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci 2002, 22:183-192.
10. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol 2010, 119:7-35.
11. Middeldorp J., Hol E.M. GFAP in health and disease. Prog Neurobiol 2011, 93:421-443.
12. Eng L.F., Vanderhaeghen J.J., Bignami A., Gerstl B. An acidic protein isolated from fibrous astrocytes. Brain Res 1971, 28:351-354.
13. Eng L.F., Ghirnikar R.S., Lee Y.L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 2000, 25:1439-1451.
14. Reeves S.A., Helman L.J., Allison A., Israel M.A. Molecular cloning and primary structure of human glial fibrillary acidic protein. Proc Natl Acad Sci U S A 1989, 86:5178-5182.
15. Condorelli D.F., Nicoletti V.G., Barresi V., Conticello S.G., Caruso A., Tendi E.A., et al. Structural features of the rat GFAP gene and identification of a novel alternative transcript. J Neurosci Res 1999, 56:219-228.
16. Zelenika D., Grima B., Brenner M., Pessac B. A novel glial fibrillary acidic protein mRNA lacking exon 1. Brain Res Mol Brain Res 1995, 30:251-258.
17. Roelofs R.F., Fischer D.F., Houtman S.H., Sluijs J.A., Van Haren W., Van Leeuwen F.W., et al. Adult human subventricular, subgranular, and subpial zones contain astrocytes with a specialized intermediate filament cytoskeleton. Glia 2005, 52:289-300.
18. Nielsen A.L., Holm I.E., Johansen M., Bonven B., Jørgensen P., Jørgensen A.L. A new splice variant of glial fibrillary acidic protein. GFAP epsilon, interacts with the presenilin proteins. J Biol Chem 2002, 277:29983-29991.
19. Blechingberg J., Holm I.E., Nielsen K.B., Jensen T.H., Jørgensen A.L., Nielsen A.L. Identification and characterization of GFAPkappa, a novel glial fibrillary acidic protein isoform. Glia 2007, 55:497-507.
20. Hol E.M., Roelofs R.F., Moraal E., Sonnemans M.A., Sluijs J.A., Proper E.A., et al. Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms. Mol Psychiatry 2003, 8:786-796.
21. Doetsch F., Caillé I., Lim D.A., García-Verdugo J.M., Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999, 97:703-716.
22. Sanai N., Tramontin A.D., Quiñones-Hinojosa A., Barbaro N.M., Gupta N., Kunwar S., et al. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature 2004, 427:740-744.
23. Quiñones-Hinojosa A., Sanai N., Soriano-Navarro M., Gonzalez-Perez O., Mirzadeh Z., Gil-Perotin S., et al. Cellular composition and cytoarchitecture of the adult human subventricular zone: a niche of neural stem cells. J Comp Neurol 2006, 494:415-434.
24. Middeldorp J., Boer K., Sluijs J.A., De Filippis L., Encha-Razavi F., Vescovi A.L., et al. GFAPdelta in radial glia and subventricular zone progenitors in the developing human cortex. Development 2010, 137:313-321.
25. Van den Berge S.A., Middeldorp J., Zhang C.E., Curtis M.A., Leonard B.W., Mastroeni D., et al. Longterm quiescent cells in the aged human subventricular neurogenic system specifically express GFAP-delta. Aging Cell 2010, 9:313-326.
26. Perng M.D., Wen S.F., Gibbon T., Middeldorp J., Sluijs J., Hol E.M., et al. Glial fibrillary acidic protein filaments can tolerate the incorporation of assembly-compromised GFAP-delta, but with consequences for filament organization and alphaB-crystallin association. Mol Biol Cell 2008, 19:4521-4533.
27. Andreiuolo F., Junier M.P., Hol E.M., Miquel C., Chimelli L., Leonard N., et al. GFAPdelta immunostaining improves visualization of normal and pathologic astrocytic heterogeneity. Neuropathology 2009, 29:31-39.
28. Sofroniew M.V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 2009, 32:638-647.
29. Kriegstein A., Alvarez-Buylla A. The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci 2009, 32:149-184.
30. Bush T.G., Savidge T.C., Freeman T.C., Cox H.J., Campbell E.A., Mucke L., et al. Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell 1998, 93:189-201.
31. Ruhl A. Glial cells in the gut. Neurogastroenterol Motil 2005, 17:777-790.
32. Zhao L., Burt A.D. The diffuse stellate cell system. J Mol Histol 2007, 38:53-64.
33. Norenberg M.D. Distribution of glutamine synthetase in the rat central nervous system. J Histochem Cytochem 1979, 27:756-762.
34. Patel A.J., Weir M.D., Hunt A., Tahourdin C.S., Thomas D.G. Distribution of glutamine synthetase and glial fibrillary acidic protein and correlation of glutamine synthetase with glutamate decarboxylase in different regions of the rat central nervous system. Brain Res 1985, 331:1-9.
35. Gonçalves C.A., Leite M.C., Nardin P. Biological and methodological features of the measurement of S100B, a putative marker of brain injury. Clin Biochem 2008, 41:755-763.
36. Lovatt D., Sonnewald U., Waagepetersen H.S., Schousboe A., He W., Lin J.H., et al. The transcriptome and metabolic gene signature of protoplasmic astrocytes in the adult murine cortex. J Neurosci 2007, 27:12255-12266.
37. Cahoy J.D., Emery B., Kaushal A., Foo L.C., Zamanian J.L., Christopherson K.S., et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 2008, 28:264-278.
38. Awasaki T., Tatsumi R., Takahashi K., Arai K., Nakanishi Y., Ueda R., et al. Essential role of the apoptotic cell engulfment genes draper and ced-6 in programmed axon pruning during Drosophila metamorphosis. Neuron 2006, 50:855-867.
39. Bishop D.L., Misgeld T., Walsh M.K., Gan W.B., Lichtman J.W. Axon branch removal at developing synapses by axosome shedding. Neuron 2004, 44:651-661.
40. Agulhon C., Petravicz J., McMullen A.B., Sweger E.J., Minton S.K., Taves S.R., et al. What is the role of astrocyte calcium in neurophysiology?. Neuron 2008, 59:932-946.
41. Schummers J., Yu H., Sur M. Tuned responses of astrocytes and their influence on hemodynamic signals in the visual cortex. Science 2008, 320:1638-1643.
42. Powell E.M., Geller H.M. Dissection of astrocyte-mediated cues in neuronal guidance and process extension. Glia 1999, 26:73-83.
43. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., et al. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131:1164-1178.
44. Lutz S.E., Zhao Y., Gulinello M., Lee S.C., Raine C.S., Brosnan C.F. Deletion of astrocyte connexins 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation. J Neurosci 2009, 29:7743-7752.
45. Pfrieger F.W., Barres B.A. Synaptic efficacy enhanced by glial cells in vitro. Science 1997, 277:1684-1687.
46. Ullian E.M., Sapperstein S.K., Christopherson K.S., Barres B.A. Control of synapse number by glia. Science 2001, 291:657-661.
47. Risher W.C., Eroglu C. Thrombospondins as key regulators of synaptogenesis in the central nervous system. Matrix Biol 2012, 31:170-177.
48. Christopherson K.S., Ullian E.M., Stokes C.C., Mullowney C.E., Hell J.W., Agah A., et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 2005, 120:421-433.
49. Mauch D.H., Nägler K., Schumacher S., Göritz C., Müller E.C., Otto A., et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001, 294:1354-1357.
50. Tran M.D., Neary J.T. Purinergic signaling induces thrombospondin-1 expression in astrocytes. Proc Natl Acad Sci U S A 2006, 103:9321-9326.
51. Boulanger L.M., Shatz C.J. Immune signalling in neural development, synaptic plasticity and disease. Nat Rev Neurosci 2004, 5:521-531.
52. Kang J., Jiang L., Goldman S.A., Nedergaard M. Astrocyte-mediated potentiation of inhibitory synaptic transmission. Nat Neurosci 1998, 1:683-692.
53. Fellin T., Pascual O., Gobbo S., Pozzan T., Haydon P.G., Carmignoto G. Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron 2004, 43:729-743.
54. Shigetomi E., Bowser D.N., Sofroniew M.V., Khakh B.S. Two forms of astrocyte calcium excitability have distinct effects on NMDA receptor-mediated slow inward currents in pyramidal neurons. J Neurosci 2008, 28:6659-6663.
55. Paukert M., Bergles D.E. Synaptic communication between neurons and NG2+ cells. Curr Opin Neurobiol 2006, 16:515-521.
56. Zhang Q., Pangrsic T., Kreft M., Krzan M., Li N., Sul J.Y., et al. Fusion-related release of glutamate from astrocytes. J Biol Chem 2004, 279:12724-12733.
57. Zhang Q., Fukuda M., van Bockstaele E., Pascual O., Haydon P.G. Synaptotagmin IV regulates glial glutamate release. Proc Natl Acad Sci U S A 2004, 101:9441-9446.
58. Wilhelm A., Volknandt W., Langer D., Nolte C., Kettenmann H., Zimmermann H. Localization of SNARE proteins and secretory organelle proteins in astrocytes in vitro and in situ. Neurosci Res 2004, 48:249-257.
59. Bezzi P., Gundersen V., Galbete J.L., Seifert G., Steinhäuser C., Pilati E., et al. Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate. Nat Neurosci 2004, 7:613-620.
60. Zhang Z., Chen G., Zhou W., Song A., Xu T., Luo Q., et al. Regulated ATP release from astrocytes through lysosome exocytosis. Nat Cell Biol 2007, 9:945-953.
61. Li D., Ropert N., Koulakoff A., Giaume C., Oheim M. Lysosomes are the major vesicular compartment undergoing Ca2+-regulated exocytosis from cortical astrocytes. J Neurosci 2008, 28:7648-7658.
62. Jaiswal J.K., Fix M., Takano T., Nedergaard M., Simon S.M. Resolving vesicle fusion from lysis to monitor calcium-triggered lysosomal exocytosis in astrocytes. Proc Natl Acad Sci U S A 2007, 104:14151-14156.
63. Pascual O., Casper K.B., Kubera C., Zhang J., Revilla-Sanchez R., Sul J.Y., et al. Astrocytic purinergic signaling coordinates synaptic networks. Science 2005, 310:113-116.
64. Panatier A., Theodosis D.T., Mothet J.P., Touquet B., Pollegioni L., Poulain D.A., et al. Glia-derived D-serine controls NMDA receptor activity and synaptic memory. Cell 2006, 125:775-784.
65. Mustafa A.K., Kim P.M., Snyder S.H. D-Serine as a putative glial neurotransmitter. Neuron Glia Biol 2004, 1:275-281.
66. Hertz L., Peng L., Dienel G.H. Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J Cereb Blood Flow Metab 2007, 27:219-249.
67. Stellwagen D., Malenka R.C. Synaptic scaling mediated by glial TNF-alpha. Nature 2006, 440:1054-1059.
68. Garcia-Segura L.M., Melcangi R.C. Steroids and glial cell function. Glia 2006, 54:485-498.
69. Araque A., Parpura V., Sanzgiri R.P., Haydon P.G. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 1999, 22:208-215.
70. Halassa M.M., Fellin T., Haydon P.G. The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol Med 2007, 13:54-63.
71. Perea G., Navarrete M., Araque A. Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 2009, 32:421-431.
72. Simard M., Nedergaard M. The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 2004, 129:877-896.
73. Obara M., Szeliga M., Albrecht J. Regulation of pH in the mammalian central nervous system under normal and pathological conditions: facts and hypotheses. Neurochem Int 2008, 52:905-919.
74. Koehler R.C., Gebremedhin D., Harder D.R. Role of astrocytes in cerebrovascular regulation. J Appl Physiol 2006, 100:307-317.
75. Gordon G.R., Mulligan S.J., MacVicar B.A. Astrocyte control of the cerebrovasculature. Glia 2007, 55:1214-1221.
76. Metea M.R., Newman E.A. Glial cells dilate and constrict blood vessels: a mechanism of neurovascular coupling. J Neurosci 2006, 26:2862-2870.
77. Zonta M., Angulo M.C., Gobbo S., Rosengarten B., Hossmann K.A., Pozzan T., et al. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 2003, 6:43-50.
78. Iadecola C., Nedergaard M. Glial regulation of the cerebral microvasculature. Nat Neurosci 2007, 10:1369-1376.
79. Wolf F., Kirchhoff F. Neuroscience. Imaging astrocyte activity. Science 2008, 320:1597-1599.
80. Takano T., Han X., Deane R., Zlokovic B., Nedergaard M. Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer's disease. Ann N Y Acad Sci 2007, 1097:40-50.
81. Phelps C.H. Barbiturate-induced glycogen accumulation in brain. An electron microscopic study. Brain Res 1972, 39:225-234.
82. Brown A.M., Ransom B.R. Astrocyte glycogen and brain energy metabolism. Glia 2007, 55:1263-1271.
83. Rouach N., Koulakoff A., Abudara V., Willecke K., Giaume C. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 2008, 322:1551-1555.
84. Abbott N.J., Ronnback L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006, 7:41-53.
85. Beck D.W., Vinters H.V., Hart M.N., Cancilla P.A. Glial cells influence polarity of the blood-brain barrier. J Neuropathol Exp Neurol 1984, 43:219-224.
86. Jackson F.R. Glial cell modulation of circadian rhythms. Glia 2011, 59:1341-1350.
87. Lavialle M., Serviere J. Circadian fluctuations in GFAP distribution in the Syrian hamster suprachiasmatic nucleus. Neuroreport 1993, 4:1243-1246.
88. Halassa M.M., Florian C., Fellin T., Munoz J.R., Lee S.Y., Abel T., et al. Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron 2009, 61:213-219.
89. Aton S.J., Colwell C.S., Harmar A.J., Waschek J., Herzog E.D. Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nat Neurosci 2005, 8:476-483.
90. Karten B., Peake K.B., Vance J.E. Mechanisms and consequences of impaired lipid trafficking in Niemann-Pick type C1-deficient mammalian cells. Biochim Biophys Acta 2009, 1791:659-670.
91. Wollmer M.A. Cholesterol-related genes in Alzheimer's disease. Biochim Biophys Acta 2010, 1801:762-773.
92. Vance J.E., Hayashi H., Karten B. Cholesterol homeostasis in neurons and glial cells. Semin Cell Dev Biol 2005, 16:193-212.
93. Hayashi H. Lipid metabolism and glial lipoproteins in the central nervous system. Biol Pharm Bull 2011, 34:453-461.
94. Hayashi H., Campenot R.B., Vance D.E., Vance J.E. Glial lipoproteins stimulate axon growth of central nervous system neurons in compartmented cultures. J Biol Chem 2004, 279:14009-14015.
95. Horsburgh K., Macrae I.M., Carswell H. Estrogen is neuroprotective via an apolipoprotein E-dependent mechanism in a mouse model of global ischemia. J Cereb Blood Flow Metab 2002, 22:1189-1195.
96. LaDu M.J., Shah J.A., Reardon C.A., Getz G.S., Bu G., Hu J. Apolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responses. Neurochem Int 2001, 39:427-434.
97. Hayashi H., Campenot R.B., Vance D.E., Vance J.E. Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1. J Neurosci 2007, 27:1933-1941.
98. Hayashi H., Campenot R.B., Vance D.E., Vance J.E. Protection of neurons from apoptosis by apolipoprotein E-containing lipoproteins does not require lipoprotein uptake and involves activation of phospholipase Cgamma1 and inhibition of calcineurin. J Biol Chem 2009, 284:29605-29613.
99. Valenza M., Rigamonti D., Goffredo D., Zuccato C., Fenu S., Jamot L., et al. Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease. J Neurosci 2005, 25:9932-9939.
100. Valenza M., Leoni V., Karasinska J.M., Petricca L., Fan J., Carroll J., et al. Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes. J Neurosci 2010, 30:10844-10850.
101. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 1993, 90:1977-1981.
102. Rebeck G.W., Reiter J.S., Strickland D.K., Hyman B.T. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993, 11:575-580.
103. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A 1993, 90:9649-9653.
104. Lois C., Alvarez-Buylla A. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci U S A 1993, 90:2074-2077.
105. Morshead C.M., Reynolds B.A., Craig C.G., McBurney M.W., Staines W.A., Morassutti D., et al. Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells. Neuron 1994, 13:1071-1082.
106. Gage F.H. Mammalian neural stem cells. Science 2000, 287:1433-1438.
107. Luskin M.B. Neuroblasts of the postnatal mammalian forebrain: their phenotype and fate. J Neurobiol 1998, 36:221-233.
108. Alvarez-Buylla A., Garcia-Verdugo J.M. Neurogenesis in adult subventricular zone. J Neurosci 2002, 22:629-634.
109. Bozoyan L., Khlghatyan J., Saghatelyan A. Astrocytes control the development of the migration-promoting vasculature scaffold in the postnatal brain via VEGF signaling. J Neurosci 2012, 32:1687-1704.
110. Curtis M.A., Kam M., Nannmark U., Anderson M.F., Axell M.Z., Wikkelso C., et al. Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science 2007, 315:1243-1249.
111. Sanai N., Nguyen T., Ihrie R.A., Mirzadeh Z., Tsai H.H., Wong M., et al. Corridors of migrating neurons in the human brain and their decline during infancy. Nature 2011, 478:382-386.
112. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat Rev Neurosci 2004, 5:146-156.
113. Bush T.G., Puvanachandra N., Horner C.H., Polito A., Ostenfeld T., Svendsen C.N., et al. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 1999, 23:297-308.
114. Faulkner J.R., Herrmann J.E., Woo M.J., Tansey K.E., Doan N.B., Sofroniew M.V., et al. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 2004, 24:2143-2155.
115. Voskuhl R.R., Peterson R.S., Song B., Ao Y., Morales L.B., Tiwari-Woodruff S., et al. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci 2009, 29:11511-11522.
116. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16:675-686.
117. Swanson R.A., Ying W., Kauppinen T.M. Astrocyte influences on ischemic neuronal death. Curr Mol Med 2004, 4:193-205.
118. Chen Y., Vartiainen N.E., Ying W., Chan P.H., Koistinaho J., Swanson R.A. Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism. J Neurochem 2001, 77:1601-1610.
119. Shih A.Y., Johnson D.A., Wong G., Kraft A.D., Jiang L., Erb H., et al. Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci 2003, 23:3394-3406.
120. Vargas M.R., Johnson D.A., Sirkis D.W., Messing A., Johnson J.A. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci 2008, 28:13574-13581.
121. Koistinaho M., Lin S., Wu X., Esterman M., Koger D., Hanson J., et al. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med 2004, 10:719-726.
122. Pekny M. Astrocytic intermediate filaments: lessons from GFAP and vimentin knock-out mice. Prog Brain Res 2001, 132:23-30.
123. Eng L.F., Lee Y.L., Kwan H., Brenner M., Messing A. Astrocytes cultured from transgenic mice carrying the added human glial fibrillary acidic protein gene contain Rosenthal fibers. J Neurosci Res 1998, 53:353-360.
124. Wilhelmsson U., Li L., Pekna M., Berthold C.H., Blom S., Eliasson C., et al. Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration. J Neurosci 2004, 24:5016-5021.
125. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997, 276:1699-1702.
126. Mitani A., Tanaka K. Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J Neurosci 2003, 23:7176-7182.
127. Watanabe T., Morimoto K., Hirao T., Suwaki H., Watase K., Tanaka K. Amygdala-kindled and pentylenetetrazole-induced seizures in glutamate transporter GLAST-deficient mice. Brain Res 1999, 845:92-96.
128. Mallolas J., Hurtado O., Castellanos M., Blanco M., Sobrino T., Serena J., et al. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. J Exp Med 2006, 203:711-717.
129. Siushansian R., Bechberger J.F., Cechetto D.F., Hachinski V.C., Naus C.C. Connexin43 null mutation increases infarct size after stroke. J Comp Neurol 2001, 440:387-394.
130. Lutz S.E., Raine C.S., Brosnan C.F. Loss of astrocyte connexins 43 and 30 does not significantly alter susceptibility or severity of acute experimental autoimmune encephalomyelitis in mice. J Neuroimmunol 2012, 245:8-14.